5 5. Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A‐Biol. 2006; 61(1):72–7.
6 6. Leong DP, Teo KK, Rangarajan S, Lopez‐Jaramillo P, Avezum A, Jr., Orlandini A, et al. Prognostic value of grip strength: Findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015; 386(9990):266–73.
7 7. Cooper R, Strand BH, Hardy R, Patel KV, Kuh D. Physical capability in mid‐life and survival over 13 years of follow‐up: British birth cohort study. BMJ 2014; 348:g2219.
8 8. Strand BH, Cooper R, Bergland A, Jorgensen L, Schirmer H, Skirbekk V, et al. The association of grip strength from midlife onwards with all‐cause and cause‐specific mortality over 17 years of follow‐up in the Tromso Study. J Epidemiol Community Health 2016; 70(12):1214–21.
9 9. Peterson SJ, Braunschweig CA. Prevalence of sarcopenia and associated outcomes in the clinical setting. Nutr Clin Pract. 2016; 31(1):40–8.
10 10. Woo J, Leung J, Sham A, Kwok T. Defining sarcopenia in terms of risk of physical limitations: A 5‐year follow‐up study of 3,153 Chinese men and women. J Am Geriatr Soc. 2009; 57(12):2224–31.
11 11. Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc. 2015; 16(3):247–52.
12 12. Woo J, Leung J. Anthropometric cut points for definition of sarcopenia based on incident mobility and physical limitation in older chinese people. J Gerontol A Biol Sci Med Sci. 2016; 71(7):935–40.
13 13. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014; 69(5):547–58.
14 14. Cruz‐Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019; 48(1):16–31.
15 15. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15(2):95–101.
16 16. Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, et al. Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study. Clin Nutr. 2012; 31(5):652–8.
17 17. Cawthon PM, Blackwell TL, Cauley J, Kado DM, Barrett‐Connor E, Lee CG, et al. Evaluation of the usefulness of consensus definitions of sarcopenia in older men: Results from the observational osteoporotic fractures in Men Cohort Study. J Am Geriatr Soc. 2015; 63(11):2247–59.
18 18. Hirschfeld HP, Kinsella R, Duque G. Osteosarcopenia: Where bone, muscle, and fat collide. Osteoporos Int. 2017; 28(10):2781–90.
19 19. Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC‐F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 2016; 7(1):28–36.
20 20. Yu R, Leung J, Woo J. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men. J Am Med Dir Assoc. 2014; 15(12):918–23.
21 21. Su Y, Woo JW, Kwok TCY. The added value of SARC‐F to prescreening using FRAX for hip fracture prevention in older community adults. J Am Med Dir Assoc. 2019; 20(1):83–9.
22 22. Yu R, Zhu LY, Chan R, Woo J. Management of sarcopenia to improve quality of life in geriatric populations. Clin Med Insights‐Ge. 2016; 9:7–14.
23 23. Beaudart C, Biver E, Reginster JY, Rizzoli R, Rolland Y, Bautmans I, et al. Development of a self‐administrated quality of life questionnaire for sarcopenia in elderly subjects: The SarQoL. Age Ageing. 2015; 44(6):960–6.
24 24. Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: Mechanistic links between common co‐morbidities. J Endocrinol. 2016; 229(2):R67–81.
25 25. Bianchi L, Volpato S. Muscle dysfunction in type 2 diabetes: A major threat to patient's mobility and independence. Acta Diabetol. 2016; 53(6):879–89.
26 26. Buch A, Carmeli E, Boker LK, Marcus Y, Shefer G, Kis O, et al. Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age‐‐An overview. Exp Gerontol. 2016; 76:25–32.
27 27. Gusmao‐Sena MH, Curvello‐Silva K, Barreto‐Medeiros JM, Da‐Cunha‐Daltro CH. Association between sarcopenic obesity and cardiovascular risk: Where are we? Nutr Hosp. 2016; 33(5):1245–55.
28 28. Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: A cross talk between age‐associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev. 2017; 35:200–21.
29 29. Tian S, Xu Y. Association of sarcopenic obesity with the risk of all‐cause mortality: A meta‐analysis of prospective cohort studies. Geriatr Gerontol Int. 2016; 16(2):155–66.
30 30. Auyeung TW, Lee JS, Leung J, Kwok T, Woo J. Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3,153 older adults‐‐An alternative measurement of sarcopenia and sarcopenic obesity. Age (Dordr) 2013; 35(4):1377–85.
31 31. Woo J, Leung J. Sarcopenic obesity revisited: Insights from the Mr and Ms Os cohort. J Am Med Dir Assoc. 2018; 19(8):679–84 e2.
32 32. Springer J, Springer JI, Anker SD. Muscle wasting and sarcopenia in heart failure and beyond: Update 2017. ESC Heart Fail 2017; 4(4):492–8.
33 33. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: A new definition. Clin Nutr. 2008; 27(6):793–9.
34 34. Menant JC, Weber F, Lo J, Sturnieks DL, Close JC, Sachdev PS, et al. Strength measures are better than muscle mass measures in predicting health‐related outcomes in older people: Time to abandon the term sarcopenia? Osteoporos Int. 2017; 28(1):59–70.
35 35. Carson RG. Get a grip: Individual variations in grip strength are a marker of brain health. Neurobiol Aging 2018; 71:189–222.
Конец ознакомительного фрагмента.
Текст предоставлен ООО «ЛитРес».
Прочитайте эту книгу целиком, купив полную легальную версию на ЛитРес.
Безопасно оплатить книгу можно банковской картой Visa, MasterCard, Maestro, со счета мобильного телефона, с платежного терминала, в салоне МТС или Связной, через PayPal, WebMoney, Яндекс.Деньги, QIWI Кошелек, бонусными картами или другим удобным Вам способом.